FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 341:1249-1255 October 21, 1999 Number 17 Next

	Full Text PDF Editorial by Utiger, R. D. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

ABSTRACT

Background In the United States, most patients with primary hyperparathyroidism have few or no symptoms. The need for parathyroidectomy to treat all patients with this disorder has therefore been questioned.

Methods We studied the clinical course and development of complications for periods of up to 10 years in 121 patients with primary hyperparathyroidism, 101 (83 percent) of whom were asymptomatic. There were 30 men and 91 women (age range, 20 to 79 years). During the study, 61 patients (50 percent) underwent parathyroidectomy, and 60 patients were followed without surgery.

Results Parathyroidectomy in patients with or without symptoms led to normalization of serum calcium concentrations and a mean (±SE) increase in lumbar-spine bone mineral density of 8±2 percent after 1 year (P=0.005) and 12±3 percent after 10 years (P=0.03). Bone mineral density of the femoral neck increased 6±1 percent after 1 year (P=0.002) and 14±4 percent after 10 years (P=0.002). Bone mineral density of the radius did not change significantly. The 52 asymptomatic patients who did not undergo surgery had no change in serum calcium concentration, urinary calcium excretion, or bone mineral density. However, 14 of these 52 patients (27 percent) had progression of disease, defined as the development of at least one new indication for parathyroidectomy. All 20 patients with symptoms had kidney stones. None of the 12 who underwent parathyroidectomy had recurrent kidney stones, whereas 6 of the 8 patients who did not undergo surgery did have a recurrence.

Conclusions In patients with primary hyperparathyroidism, parathyroidectomy results in the normalization of biochemical values and increased bone mineral density. Most asymptomatic patients who did not undergo surgery did not have progression of disease, but approximately one quarter of them did have some progression.

Source Information

From the Departments of Medicine (S.J.S., E. Shane, T.P.J., E. Siris, J.P.B.) and Pharmacology (J.P.B.), College of Physicians and Surgeons, Columbia University, New York.

Address reprint requests to Dr. Silverberg at the Department of Medicine, College of Physicians and Surgeons, 630 W. 168th St., New York, NY 10032.

Full Text of this Article

This article has been cited by other articles:

• Farag, N., Delbanco, T., Strewler, G. J. (2008). Update: A 64-Year-Old Woman With Primary Hyperparathyroidism. JAMA 300: 2044-2045 [Full Text]  
• El-Hajj Fuleihan, G. (2008). Hyperparathyroidism: Time to Reconsider Current Clinical Decision Paradigms?. J. Clin. Endocrinol. Metab. 93: 3302-3304 [Full Text]  
• Horwitz, M. J., Stewart, A. F. (2008). Hypoparathyroidism: Is It Time for Replacement Therapy?. J. Clin. Endocrinol. Metab. 93: 3307-3309 [Full Text]  
• Rubin, M. R., Bilezikian, J. P., McMahon, D. J., Jacobs, T., Shane, E., Siris, E., Udesky, J., Silverberg, S. J. (2008). The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 Years. J. Clin. Endocrinol. Metab. 93: 3462-3470 [Abstract] [Full Text]  
• Kaji, H., Yamauchi, M., Nomura, R., Sugimoto, T. (2008). Improved Peripheral Cortical Bone Geometry after Surgical Treatment of Primary Hyperparathyroidism in Postmenopausal Women. J. Clin. Endocrinol. Metab. 93: 3045-3050 [Abstract] [Full Text]  
• Nakchbandi, I. A., Lang, R., Kinder, B., Insogna, K. L. (2008). The Role of the Receptor Activator of Nuclear Factor-{kappa}B Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 93: 967-973 [Abstract] [Full Text]  
• Mazzaglia, P. J., Berber, E., Kovach, A., Milas, M., Esselstyn, C., Siperstein, A. E. (2008). The Changing Presentation of Hyperparathyroidism Over 3 Decades. Arch Surg 143: 260-266 [Abstract] [Full Text]  
• Lowe, H., McMahon, D. J., Rubin, M. R., Bilezikian, J. P., Silverberg, S. J. (2007). Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype. J. Clin. Endocrinol. Metab. 92: 3001-3005 [Abstract] [Full Text]  
• Ambrogini, E., Cetani, F., Cianferotti, L., Vignali, E., Banti, C., Viccica, G., Oppo, A., Miccoli, P., Berti, P., Bilezikian, J. P., Pinchera, A., Marcocci, C. (2007). Surgery or Surveillance for Mild Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Clinical Trial. J. Clin. Endocrinol. Metab. 92: 3114-3121 [Abstract] [Full Text]  
• Suliburk, J. W., Perrier, N. D. (2007). Primary Hyperparathyroidism. The Oncologist 12: 644-653 [Abstract] [Full Text]  
• Walker, M. D., Silverberg, S. J. (2007). Parathyroidectomy in Asymptomatic Primary Hyperparathyroidism: Improves "Bones" but not "Psychic Moans". J. Clin. Endocrinol. Metab. 92: 1613-1615 [Full Text]  
• Bollerslev, J., Jansson, S., Mollerup, C. L., Nordenstrom, J., Lundgren, E., Torring, O., Varhaug, J.-E., Baranowski, M., Aanderud, S., Franco, C., Freyschuss, B., Isaksen, G. A., Ueland, T., Rosen, T., on behalf on the SIPH Study Group, (2007). Medical Observation, Compared with Parathyroidectomy, for Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial. J. Clin. Endocrinol. Metab. 92: 1687-1692 [Abstract] [Full Text]  
• Corbetta, S, Eller-Vainicher, C, Filopanti, M, Saeli, P, Vezzoli, G, Arcidiacono, T, Loli, P, Syren, M L, Soldati, L, Beck-Peccoz, P, Spada, A (2006). R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism.. Eur J Endocrinol 155: 687-692 [Abstract] [Full Text]  
• VanderWalde, L. H., Liu, I.-L. A., O'Connell, T. X., Haigh, P. I. (2006). The Effect of Parathyroidectomy on Bone Fracture Risk in Patients With Primary Hyperparathyroidism. Arch Surg 141: 885-891 [Abstract] [Full Text]  
• Hagstrom, E., Lundgren, E., Rastad, J., Hellman, P. (2006). Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening.. Eur J Endocrinol 155: 33-39 [Abstract] [Full Text]  
• Charopoulos, I., Tournis, S., Trovas, G., Raptou, P., Kaldrymides, P., Skarandavos, G., Katsalira, K., Lyritis, G. P. (2006). Effect of Primary Hyperparathyroidism on Volumetric Bone Mineral Density and Bone Geometry Assessed by Peripheral Quantitative Computed Tomography in Postmenopausal Women. J. Clin. Endocrinol. Metab. 91: 1748-1753 [Abstract] [Full Text]  
• Sejean, K., Calmus, S., Durand-Zaleski, I., Bonnichon, P., Thomopoulos, P., Cormier, C., Legmann, P., Richard, B., Bertagna, X. Y, Vidal-Trecan, G. M (2005). Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis. Eur J Endocrinol 153: 915-927 [Abstract] [Full Text]  
• Brown, E. M. (2005). Medical Therapy of Primary Hyperparathyroidism: Are We There Yet?. IBMS BoneKEy 2: 5-8 [Full Text]  
• Grant, C. S., Thompson, G., Farley, D., van Heerden, J. (2005). Primary Hyperparathyroidism Surgical Management Since the Introduction of Minimally Invasive Parathyroidectomy: Mayo Clinic Experience. Arch Surg 140: 472-479 [Abstract] [Full Text]  
• Strewler, G. J. (2005). A 64-Year-Old Woman With Primary Hyperparathyroidism. JAMA 293: 1772-1779 [Full Text]  
• Bolland, M. J., Grey, A. B., Gamble, G. D., Reid, I. R. (2005). Association between Primary Hyperparathyroidism and Increased Body Weight: A Meta-Analysis. J. Clin. Endocrinol. Metab. 90: 1525-1530 [Abstract] [Full Text]  
• Fleischer, J., Becker, C., Hamele-Bena, D., Breen, T. L., Silverberg, S. J. (2004). Oxyphil Parathyroid Adenoma: A Malignant Presentation of a Benign Disease. J. Clin. Endocrinol. Metab. 89: 5948-5951 [Abstract] [Full Text]  
• Rao, D. S., Phillips, E. R., Divine, G. W., Talpos, G. B. (2004). Randomized Controlled Clinical Trial of Surgery Versus No Surgery in Patients with Mild Asymptomatic Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 89: 5415-5422 [Abstract] [Full Text]  
• Joy, M. S, Kshirsagar, A. V, Franceschini, N. (2004). Calcimimetics and the Treatment of Primary and Secondary Hyperparathyroidism. The Annals of Pharmacotherapy 38: 1871-1880 [Abstract] [Full Text]  
• Khan, A. A., Bilezikian, J. P., Kung, A. W. C., Ahmed, M. M., Dubois, S. J., Ho, A. Y. Y., Schussheim, D., Rubin, M. R., Shaikh, A. M., Silverberg, S. J., Standish, T. I., Syed, Z., Syed, Z. A. (2004). Alendronate in Primary Hyperparathyroidism: A Double-Blind, Randomized, Placebo-Controlled Trial. J. Clin. Endocrinol. Metab. 89: 3319-3325 [Abstract] [Full Text]  
• Bilezikian, J. P., Silverberg, S. J. (2004). Asymptomatic Primary Hyperparathyroidism. NEJM 350: 1746-1751 [Full Text]  
• Francis, R.M., Baillie, S.P., Chuck, A.J., Crook, P.R., Dunn, N., Fordham, J.N., Kelly, C., Rodgers, A. (2004). Acute and long-term management of patients with vertebral fractures. QJM 97: 63-74 [Abstract] [Full Text]  
• Lo, C.-Y., Chan, W.-F., Kung, A. W. C., Lam, K.-Y., Tam, S. C. F., Lam, K. S. L. (2004). Surgical Treatment for Primary Hyperparathyroidism in Hong Kong: Changes in Clinical Pattern Over 3 Decades. Arch Surg 139: 77-82 [Abstract] [Full Text]  
• Shoback, D. M., Bilezikian, J. P., Turner, S. A., McCary, L. C., Guo, M. D., Peacock, M. (2003). The Calcimimetic Cinacalcet Normalizes Serum Calcium in Subjects with Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 88: 5644-5649 [Abstract] [Full Text]  
• Silverberg, S. J., Bilezikian, J. P. (2003). "Incipient" Primary Hyperparathyroidism: A "Forme Fruste" of an Old Disease. J. Clin. Endocrinol. Metab. 88: 5348-5352 [Abstract] [Full Text]  
• Maruani, G., Hertig, A., Paillard, M., Houillier, P. (2003). Normocalcemic Primary Hyperparathyroidism: Evidence for a Generalized Target-Tissue Resistance to Parathyroid Hormone. J. Clin. Endocrinol. Metab. 88: 4641-4648 [Abstract] [Full Text]  
• Silverberg, S. J., Gao, P., Brown, I., LoGerfo, P., Cantor, T. L., Bilezikian, J. P. (2003). Clinical Utility of an Immunoradiometric Assay for Parathyroid Hormone (1-84) in Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 88: 4725-4730 [Abstract] [Full Text]  
• Clark, O. H. (2003). How Should Patients with Primary Hyperparathyroidism Be Treated?. J. Clin. Endocrinol. Metab. 88: 3011-3014 [Full Text]  
• Fallo, F., Camporese, G., Capitelli, E., Andreozzi, G. M., Mantero, F., Lumachi, F. (2003). Ultrasound Evaluation of Carotid Artery in Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 88: 2096-2099 [Abstract] [Full Text]  
• Chow, C. C., Chan, W. B., Li, J. K. Y., Chan, N. N., Chan, M. H. M., Ko, G. T. C., Lo, K. W., Cockram, C. S. (2003). Oral Alendronate Increases Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 88: 581-587 [Abstract] [Full Text]  
• Nakchbandi, I. A., Mitnick, M. A., Lang, R., Gundberg, C., Kinder, B., Insogna, K. (2002). Circulating Levels of Interleukin-6 Soluble Receptor Predict Rates of Bone Loss in Patients with Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 87: 4946-4951 [Abstract] [Full Text]  
• Watson, L. C., Marx, C. E. (2002). New Onset of Neuropsychiatric Symptoms in the Elderly: Possible Primary Hyperparathyroidism. Psychosomatics 43: 413-417 [Abstract] [Full Text]  
• Sackett, W. R., Barraclough, B., Reeve, T. S., Delbridge, L. W. (2002). Worldwide Trends in the Surgical Treatment of Primary Hyperparathyroidism in the Era of Minimally Invasive Parathyroidectomy. Arch Surg 137: 1055-1059 [Abstract] [Full Text]  
• Tuck, S P, Francis, R M (2002). Osteoporosis. Postgrad. Med. J. 78: 526-532 [Abstract] [Full Text]  
• Weis, U., Meeking, D.R., Cummings, M.H. (2002). Severe osteoporosis and autonomous hyperparathyroidism: making the numbers add up. QJM 95: 255-257 [Full Text]  
• Arnulf, B., Bengoufa, D., Sarfati, E., Toubert, M.-E., Meignin, V., Brouet, J.-C., Fermand, J.-P. (2002). Prevalence of Monoclonal Gammopathy in Patients With Primary Hyperparathyroidism: A Prospective Study. Arch Intern Med 162: 464-467 [Abstract] [Full Text]  
• McGreal, G., Winter, D.C., Sookhai, S., Evoy, D., Ryan, M., O'Sullivan, G.C., Redmond, H.P. (2001). Minimally Invasive, Radioguided Surgery for Primary Hyperparathyroidism. Ann. Surg. Oncol. 8: 856-860 [Abstract] [Full Text]  
• Rubin, M. R., LiVolsi, V. A., Bandeira, F., Caldas, G., Bilezikian, J. P. (2001). Tc99m-Sestamibi Uptake in Osteitis Fibrosa Cystica Simulating Metastatic Bone Disease. J. Clin. Endocrinol. Metab. 86: 5138-5141 [Full Text]  
• Prager, G., Czerny, C., Kurtaran, A., Passler, C., Scheuba, C., Bieglmayer, C., Niederle, B. (2001). Minimally Invasive Open Parathyroidectomy in an Endemic Goiter Area: A Prospective Study. Arch Surg 136: 810-816 [Abstract] [Full Text]  
• Rose, D. M., Wood, T. F., Van Herle, A. J., Cohan, P., Singer, F. R., Giuliano, A. E. (2001). Long-term Management and Outcome of Parathyroidectomy for Sporadic Primary Multiple-Gland Disease. Arch Surg 136: 621-626 [Abstract] [Full Text]  
• Rosen, C. J., Bilezikian, J. P. (2001). Anabolic Therapy for Osteoporosis. J. Clin. Endocrinol. Metab. 86: 957-964 [Abstract] [Full Text]  
• Marx, S. J. (2000). Hyperparathyroid and Hypoparathyroid Disorders. NEJM 343: 1863-1875 [Full Text]  
• Shonni J. Silverberg;, (2000). Cardiovascular Disease in Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 85: 3513-3514 [Full Text]  
• Vestergaard, P., Mollerup, C. L, Frøkjær, V. G., Christiansen, P., Blichert-Toft, M., Mosekilde, L. (2000). Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 321: 598-602 [Abstract] [Full Text]  
• Irvin III, G. L., Carneiro, D. M. (2000). Management Changes in Primary Hyperparathyroidism. JAMA 284: 934-936 [Full Text]  
• Siminoski, K. (2000). Asymptomatic hyperparathyroidism: Is the pendulum swinging back?. CMAJ 163: 173-175 [Full Text]  
• Khan, A., Bilezikian, J. (2000). Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 163: 184-187 [Abstract] [Full Text]  
• (1999). Natural History of Primary Hyperparathyroidism. JWatch General 1999: 1-1 [Full Text]  
• Utiger, R. D. (1999). Treatment of Primary Hyperparathyroidism. NEJM 341: 1301-1302 [Full Text]